Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1928 1
1929 1
1932 1
1933 1
1934 1
1936 1
1937 1
1938 2
1946 2
1947 2
1948 1
1949 1
1950 1
1951 1
1952 2
1953 2
1954 3
1955 7
1956 2
1957 6
1958 2
1959 4
1960 2
1961 1
1962 2
1963 3
1964 4
1965 5
1966 8
1968 3
1969 4
1970 4
1971 15
1972 10
1973 13
1974 17
1975 13
1976 14
1977 8
1978 10
1979 6
1980 9
1981 5
1982 2
1983 3
1984 4
1985 3
1986 2
1987 1
1988 4
1989 3
1990 1
1991 2
1992 2
1993 5
1995 3
1996 4
1997 7
1998 4
1999 9
2000 8
2001 8
2002 10
2003 8
2004 11
2005 11
2006 10
2007 11
2008 8
2009 14
2010 12
2011 7
2012 14
2013 12
2014 11
2015 14
2016 23
2017 22
2018 15
2019 22
2020 30
2021 44
2022 31
2023 23
2024 14
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

626 results

Results by year

Filters applied: . Clear all
Page 1
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
Sallman DA, Kerre T, Havelange V, Poiré X, Lewalle P, Wang ES, Brayer JB, Davila ML, Moors I, Machiels JP, Awada A, Alcantar-Orozco EM, Borissova R, Braun N, Dheur MS, Gilham DE, Lonez C, Lehmann FF, Flament A. Sallman DA, et al. Among authors: lehmann ff. Lancet Haematol. 2023 Mar;10(3):e191-e202. doi: 10.1016/S2352-3026(22)00378-7. Epub 2023 Feb 7. Lancet Haematol. 2023. PMID: 36764323 Clinical Trial.
mTOR signaling mediates ILC3-driven immunopathology.
Teufel C, Horvath E, Peter A, Ercan C, Piscuoglio S, Hall MN, Finke D, Lehmann FM. Teufel C, et al. Among authors: lehmann fm. Mucosal Immunol. 2021 Nov;14(6):1323-1334. doi: 10.1038/s41385-021-00432-4. Epub 2021 Aug 2. Mucosal Immunol. 2021. PMID: 34341503 Free PMC article.
Celyad's novel CAR T-cell therapy for solid malignancies.
Lonez C, Hendlisz A, Shaza L, Aftimos P, Vouche M, Donckier V, Machiels JH, Van Den Eynde M, Canon JL, Carrasco J, Odunsi K, Sahebjam S, Rottey S, Braun N, Verma B, Gilham DE, Lehmann FF. Lonez C, et al. Among authors: lehmann ff. Curr Res Transl Med. 2018 May;66(2):53-56. doi: 10.1016/j.retram.2018.03.001. Epub 2018 Apr 4. Curr Res Transl Med. 2018. PMID: 29625833 Review.
[Changing structures--Integrating health].
Plaumann M, Lehmann F, Pawils S, Walter U. Plaumann M, et al. Among authors: lehmann f. Gesundheitswesen. 2015 Sep;77 Suppl 1:S109-11. doi: 10.1055/s-0035-1559786. Epub 2015 Sep 16. Gesundheitswesen. 2015. PMID: 26375181 German.
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, Vanpouille-Box C, Wennerberg E, Pilones KA, Formenti SC, Demaria S, Tang H, Wang Y, Fu YX, Dummer R, Puzanov I, Tarhini A, Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sanders C, Kirkwood JM, Chen THT, Maurer M, Korman AJ, Zarour HM, Stroncek DF, Huber V, Rivoltini L, Thurin M, Rau T, Lugli A, Pagès F, Camarero J, Sancho A, Jommi C, de Coaña YP, Wolodarski M, Yoshimoto Y, Gentilcore G, Poschke I, Masucci GV, Hansson J, Kiessling R, Scognamiglio G, Sabbatino F, Marino FZ, Anniciello AM, Cantile M, Cerrone M, Scala S, D’alterio C, Ianaro A, Cirin G, Liguori G, Bott G, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Testori A, Lorigan P, Sosman JA, Flaherty KT, Yue H, Coleman S, Caro I, Hauschild A, McArthur GA, Sznol M, Callahan MK, Kluger H, Postow MA, Gordan R, Segal NH, Rizvi NA, Lesokhin A, Atkins MB, Burke MM, Ralabate A, Rivera A, Kronenberg SA, Agunwamba B, Ruisi M, Horak C, Jiang J, Wolchok J, Ascierto PA, Liszkay G, Maio M, Mandalà M, Demidov L, Stoyakovskiy D, Thomas L, de la Cruz-Me… See abstract for full author list ➔ Nanda VGY, et al. Among authors: lehmann ff. J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2. J Transl Med. 2016. PMID: 27461275 Free PMC article.
Melflufen - a peptidase-potentiated alkylating agent in clinical trials.
Wickström M, Nygren P, Larsson R, Harmenberg J, Lindberg J, Sjöberg P, Jerling M, Lehmann F, Richardson P, Anderson K, Chauhan D, Gullbo J. Wickström M, et al. Among authors: lehmann f. Oncotarget. 2017 Jun 8;8(39):66641-66655. doi: 10.18632/oncotarget.18420. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029544 Free PMC article. Review.
[Tumor antigens].
Lehmann FG. Lehmann FG. Dtsch Med Wochenschr. 1974 Mar 1;99(9):410-3. doi: 10.1055/s-0028-1107774. Dtsch Med Wochenschr. 1974. PMID: 4828638 German. No abstract available.
A model of porcine polymicrobial septic shock.
Zurek-Leffers FM, Lehmann F, Brabenec L, Kintrup S, Hellenthal KEM, Mersjann K, Kneifel F, Hessler M, Arnemann PH, Kampmeier TG, Ertmer C, Kellner P, Wagner NM. Zurek-Leffers FM, et al. Among authors: lehmann f. Intensive Care Med Exp. 2023 Jun 2;11(1):31. doi: 10.1186/s40635-023-00513-7. Intensive Care Med Exp. 2023. PMID: 37264259 Free PMC article.
626 results